Keyphrases
Modified Delphi Consensus
100%
Delphi Consensus
100%
Chimeric Antigen Receptor T-cell Therapy
100%
Patient-Reported Outcomes Measurement Information System (PROMIS)
100%
Electronic Patient-reported Outcome (ePRO)
100%
Measure Selection
100%
Symptom Burden
71%
Treatment Tolerability
42%
Impact of Cancer
28%
Quality of Life
28%
Online Survey
28%
Healthcare Research
28%
Chimeric Antigen Receptor T Cells (CAR-T)
28%
Consensus Conference
28%
Health-related Quality of Life
28%
Patient-reported Outcomes
28%
Cancer Antigen
28%
National Institute for Health Research
28%
Cell Therapy
28%
Healthcare Professionals
28%
Symptom Impact
28%
Patient Selection
28%
UK National Health Service
14%
Healthcare
14%
Clinical Setting
14%
COnsensus-based Standards for the Selection of Health Measurement INstruments (COSMIN)
14%
Nineteen
14%
PubMed
14%
Threshold Criterion
14%
Cancer Treatment
14%
Modified Delphi Study
14%
Cancer Burden
14%
Measurement Domain
14%
Delphi Method
14%
Quality of Life Domains
14%
Concept of Life
14%
Clinical Population
14%
Social Care
14%
Cell Treatment
14%
Concept Mapping
14%
Professional Networks
14%
Comets
14%
Health-related Quality of Life Assessments
14%
Patient Subgroups
14%
Clinical Management
14%
Hematological Cancer
14%
Database Search
14%
Consensus Methods
14%
Conceptual Coverage
14%
EQ-5D-5L
14%
Monitoring Adverse Events
14%
Chronic Illness
14%
Health Departments
14%
Stopping Criterion
14%
Domain Mapping
14%
Specific Patient
14%
Impact Domains
14%
Cancer-specific
14%
Therapy Treatment
14%
National Health Service
14%
Functional Assessment
14%
Adult Cancer Survivors
14%
Global Indicators
14%
Delphi Panel
14%
Ease of Understanding
14%
Nursing and Health Professions
Patient-Reported Outcome
100%
Chimeric Antigen Receptor T-Cell Immunotherapy
100%
Quality of Life
38%
Malignant Neoplasm
30%
Socialized Medicine
15%
Chimeric Antigen Receptor T-Cell
15%
Sample Size
7%
Cancer Therapy
7%
Functional Assessment
7%
Clinical Population
7%
Adverse Event
7%
Medline
7%
Clinical Management
7%
Chronic Disease
7%
Cell Therapy
7%
Medicine and Dentistry
Chimeric Antigen Receptor T-Cell Immunotherapy
100%
Patient-Reported Outcome
100%
Quality of Life
38%
Malignant Neoplasm
30%
Chimeric Antigen Receptor T-Cell
15%
National Health Service
15%
Concept Mapping
7%
Adverse Event
7%
Clinical Population
7%
Hematological Cancer
7%
Chronic Disease
7%
Cell Therapy
7%
Cancer Treatment
7%
Functional Assessment
7%
Clinical Management
7%